SEOUL, South Korea, June 21 — Genuine Dose, the company behind the NMN-containing product 'NAD+ Peak,' announced on June 21 that it has officially decided to expand into overseas markets, following the eighth consecutive sellout of its flagship product.
Since its launch, 'NAD+ Peak' has sold out quickly after each restock, recording eight sellouts to date. The company attributes this to a stable customer base built largely through word of mouth among existing users, without any large-scale marketing campaign.
NMN (nicotinamide mononucleotide), the key ingredient in 'NAD+ Peak,' is a compound drawing growing interest from researchers in Korea and abroad, with studies exploring its potential connection to aging and cognitive function. As leading researchers worldwide — including Professor David Sinclair of Harvard Medical School — have published a series of studies on NMN, public interest in the ingredient has also risen. Against this backdrop, consumer inquiries about NMN-containing products have been increasing overall.
This interest has spread beyond Korea to overseas consumers. According to the company, inquiries from international customers regarding purchasing and distribution have continued steadily through word of mouth, prompting it to pursue a full-scale global expansion.
"Based on the quality and customer satisfaction we have built in the domestic market, we expect to demonstrate strong competitiveness in overseas markets as well," a Genuine Dose representative said. "We are carefully preparing our market-entry strategy to meet local demand."
Genuine Dose has launched an internal task force (TF) to develop its overseas expansion strategy and partnership plans. Further details, including target countries and timelines, will be announced at a later date.
